reglab/statecodes huggingface dataset:
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1927.03 - Persons required to be permitted; formal hearing; disciplinary action

32-1927.03.
Persons required to be permitted;  formal hearing;  disciplinary action
A. A person that resides in this state or in any other jurisdiction and that sells a narcotic or other controlled substance,  a prescription-only drug or device,  a nonprescription drug,  a precursor chemical or a restricted chemical within or into this state shall hold a valid board-issued permit. If the person does not hold a valid board-issued permit,  the person is subject to disciplinary action by the board.
B. A person that after a formal hearing is found by the board to be in violation of subsection A of this section may be subject to a civil penalty not to exceed one thousand dollars for each violation of this chapter or a rule adopted pursuant to this chapter.
C. The board may charge the cost of a formal hearing to the person that the board finds to be in violation of this chapter or a rule adopted pursuant to this chapter or whose employee the board finds to be in violation of this chapter or a rule adopted pursuant to this chapter.
D. The board on its own motion or in response to a complaint may inspect or investigate,  or delegate to the executive director the authority to inspect or investigate,  any evidence that appears to show a person is or may be acting in violation of subsection A of this section. The board may:
1. Send,  or delegate to the executive director the authority to send,  a cease and desist letter regarding the person's unauthorized business in this state.
2. Request a conference with the person if the board believes the information is or may be true. If the person refuses the invitation or fails to appear for the conference and the investigation indicates that grounds may exist for the board to impose a civil penalty,  the board shall issue a formal notice that a hearing be held pursuant to title 41,  chapter 6,  article 10.
3. Dismiss the complaint if the complaint is without merit.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1928 - Hearings; restraining order; judicial review

32-1928.
Hearings;  restraining order;  judicial review
A. Except as provided in subsection B of this section,  a license shall be denied,  revoked or suspended or a pharmacist or pharmacy intern shall be placed on probation or censured and a civil penalty imposed only after due notice and a hearing pursuant to title 41,  chapter 6,  article 10. A licensee shall respond in writing to the board when the licensee receives notice of the hearing.
B. If the board has reasonable grounds to believe and finds that the licensee has been guilty of deliberate and wilful violations,  or that the public health,  safety and welfare imperatively require immediate action,  and incorporates a finding to that effect in its order,  the board may order a summary suspension of the license pending a hearing. If the board issues an order of summary suspension,  it shall serve the licensee with written notice of the complaint and hearing setting forth the charges and informing the licensee of the licensee's right to the hearing. The board shall institute the hearing within ten days after ordering the summary suspension. Service shall be by personal service as provided by the Arizona rules of civil procedure.
C. Except as provided in section 41-1092.08,  subsection H,  final decisions of the board are subject to judicial review pursuant to title 12,  chapter 7,  article 6.
D. With or without conditions,  the board may reinstate the license of any pharmacist or pharmacy intern that it has placed on probation or whose license it has suspended or revoked.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1929 - Biennial registration of pharmacies, wholesalers, third-party logistics providers, manufacturers and similar places; application

32-1929.
Biennial registration of pharmacies,  wholesalers,  third-party logistics providers,  manufacturers and similar places;  application
A. Except as provided in section 32-4301,  the board shall require and provide for biennial registration of every pharmacy,  wholesaler,  third-party logistics provider and manufacturer and any other place in which or from which drugs are sold,  compounded,  dispensed,  stocked,  exposed,  manufactured or offered for sale.
B. Any person desiring to operate,  maintain,  open or establish a pharmacy,  wholesaling firm or manufacturing plant,  or any other place in which or from which drugs are manufactured,  compounded,  dispensed,  stocked,  exposed,  sold or offered for sale,  shall apply to the board for a permit before engaging in any such activity.
C. The application for a permit to operate a pharmacy,  drug manufacturing facility or wholesaling facility in this state shall be made on a form prescribed and furnished by the board,  which,  when properly executed,  indicates the ownership,  trustee,  receiver or other person or persons desiring the permit,  including the pharmacist responsible to the board for the operation of a pharmacy or drug manufacturing facility,  or other individual approved by and responsible to the board for the operation of wholesaling facilities,  as well as the location,  including the street name and number,  and such other information as required by the board to establish the identity,  exact location and extent of activities,  in which or from which drugs are sold,  manufactured,  compounded,  dispensed,  stocked,  exposed or offered for sale.
D. The application for a permit to operate a pharmacy,  drug manufacturing facility or wholesaling facility outside of this state that will dispense,  sell,  transfer or distribute drugs into this state shall be made on a form prescribed and furnished by the board,  which,  when properly executed,  indicates the ownership,  trustee,  receiver or other person or persons desiring the permit,  including the individual approved by and responsible to the board for the operation of the pharmacy,  drug manufacturing facility or wholesaling facility,  as well as the location,  including the street name and number,  and such other information as required by the board to establish the identity,  exact location and extent of activities,  in which or from which drugs are sold,  manufactured,  compounded,  dispensed,  stocked,  exposed or offered for sale.
E. If it is desired to operate,  maintain,  open or establish more than one pharmacy,  or any other place of business in which or from which drugs are sold,  manufactured,  compounded,  dispensed,  stocked,  exposed or offered for sale,  a separate application shall be made and a separate permit shall be issued for each place,  business or outlet.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1930 - Types of permits; restrictions on permits; discontinuance of pharmacy permit

32-1930.
Types of permits;  restrictions on permits;  discontinuance of pharmacy permit
A. On application,  the board may issue the following classes or kinds of permits:
1. If approved by the board,  a pharmacy,  limited service pharmacy,  automated prescription-dispensing kiosk,  full service wholesale drug,  third-party logistics provider,  nonprescription drug wholesale and drug manufacturer's permit.
2. Drug packager or drug prepackager permit to an individual or establishment that is currently listed by the United States food and drug administration and has met the requirements of that agency to purchase,  repackage,  relabel or otherwise alter the manufacturer's original package of an approved drug product with the intent of reselling these items to persons or businesses authorized to possess or resell the repackaged,  prepackaged or relabeled drug.
3. A durable medical equipment distributor and compressed medical gas distributor permit and a durable medical equipment supplier and compressed medical gas supplier permit.
B. The board shall deny or revoke a pharmacy permit if a medical practitioner receives compensation,  either directly or indirectly,  from a pharmacy as a result of the practitioner's prescription orders. This does not include compensation to a medical practitioner who is the owner of a building where space is leased to a pharmacy at the prevailing rate,  not resulting in a rebate to the medical practitioner.
C. If a pharmacy permanently discontinues operation,  the permittee shall immediately surrender the permit to the executive director. The permittee shall remove all drug signs and symbols,  either within or without the premises,  and shall remove or destroy all drugs,  devices,  poisons and hazardous substances.
D. An automated prescription-dispensing kiosk may not contain or dispense a controlled substance as defined in section 36-2501 and the controlled substances act (P.L. 91-513;  84 Stat. 1242;  21 United States Code section 802).
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1932.01 - Substance abuse treatment and rehabilitation program; private contract; funding

32-1932.01.
Substance abuse treatment and rehabilitation program;  private contract;  funding
A. The board may establish a program for the treatment and rehabilitation of licensees who are impaired by alcohol or drug abuse. This program shall include education,  intervention,  therapeutic treatment and posttreatment monitoring and support.
B. The board may contract with other organizations to operate the program established pursuant to subsection A of this section. A contract with a private organization shall include the following requirements:
1. Periodic reports to the board regarding treatment program activity.
2. Pursuant to a written request by the board or its executive director,  release of all treatment records.
3. Quarterly reports to the board,  by case number,  regarding each participant's diagnosis,  prognosis and recommendations for continuing care,  treatment and supervision.
4. Immediate reporting to the board of the name of an impaired licensee who the treating organization believes to be a danger to self or others.
5. Reports to the board,  as soon as possible,  of the name of a participant who refuses to submit to treatment or whose impairment is not substantially alleviated through treatment.
C. The board may allocate an amount of not to exceed twenty dollars from each fee it collects from biennial renewal licenses pursuant to section 32-1925 for the operation of the program established by this section.
D. A licensee who is impaired by alcohol or drug abuse may enter into a stipulation order with the board,  or the licensee may be placed on probation or be subject to other action as provided by law.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1933 - Display of license or permit

32-1933.
Display of license or permit
A. The holder of a permit granted under this chapter shall conspicuously display it in the location to which it applies.
B. A licensee shall maintain the licensee's current renewal license or duplicate current renewal license,  if practicing in more than one location,  in the practice site for inspection by the board or its designee or review by the public.
C. If a licensee practices in more than one place,  the board may issue one or more duplicate current renewal licenses to the licensee on payment of a fee of not more than twenty-five dollars for each duplicate current renewal license.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1934 - Remote hospital-site pharmacy permittee; requirements

32-1934.
Remote hospital-site pharmacy permittee;  requirements
A. A remote hospital-site pharmacy permittee shall comply with all the provisions of this chapter requiring registration and regulation of pharmacies,  with board rules and with applicable federal law.
B. A remote hospital-site pharmacy permittee shall ensure that:
1. The remote hospital-site pharmacy is supervised by a pharmacist who is located in this state and who is employed by the hospital.
2. The remote hospital-site pharmacy displays a sign visible to the public identifying the pharmacy as a remote hospital-site pharmacy and warning that the remote hospital-site pharmacy is under continuous video surveillance that is recorded and retained.
3. The remote hospital-site pharmacy uses an electronic recordkeeping system that is shared with and accessible by the pharmacy located in the hospital.
4. All drugs and devices furnished from the remote hospital-site pharmacy to patients of the satellite facility are verified by a pharmacist who is licensed in this state and who is employed by the hospital. If the satellite facility is an emergency department of the hospital,  in the pharmacist's absence a registered nurse practitioner or professional nurse who is licensed pursuant to chapter 15 of this title,  a physician who is licensed pursuant to chapter 13 or 17 of this title or a physician assistant who is licensed pursuant to chapter 25 of this title may obtain from the remote hospital-site pharmacy necessary drugs and devices that are ordered by a medical practitioner and that are needed by a patient in an emergency,  according to policies approved by the hospital.
5. The pharmacist in charge develops and implements procedures regarding obtaining,  storing and dispensing drugs for inpatient administration and devices and recordkeeping requirements.
6. If a noncontrolled substance single-patient use multidose medication was dispensed to a patient in a container for inpatient administration,  the remote hospital-site pharmacy dispenses that medication for the patient on discharge,  if needed.
C. A remote hospital-site pharmacy permittee shall:
1. Develop and maintain a policy and procedures manual and make the manual available to the board or its agent on request.
2. Maintain a perpetual inventory of controlled substances.
3. Ensure that there is continuous video surveillance of the remote hospital-site pharmacy and maintain recorded videos for at least sixty days.
4. Ensure that the pharmacist in charge from the pharmacy located in the hospital reconciles the inventory of controlled substances on a monthly basis.
D. A pharmacist may engage simultaneously in the practice of pharmacy at a reasonable number of remote hospital-site pharmacies as determined and approved by the hospital.
E. The board may adopt additional rules that are necessary to implement this section.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1936 - Mandatory continuing professional pharmacy education

32-1936.
Mandatory continuing professional pharmacy education
A. All pharmacists licensed in this state shall satisfactorily complete approved courses of continuing professional pharmacy education or continue their education by other means in accordance with rules adopted by the board before renewing a license.
B. The board by rule shall establish the form and content of courses for continuing professional pharmacy education and the number of hours required for renewal of a license.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1937 - Exceptions to continuing education requirements

32-1937.
Exceptions to continuing education requirements
A. The requirements of continuing professional pharmacy education provided in section 32-1936 do not apply to licensees beginning the date of initial licensure until the date of the first license renewal.
B. The board may make exceptions from the requirements of section 32-1936 in emergency or hardship cases or for good cause shown based on a written request for an exception from the requirements.
C. Pharmacists who are exempted from the requirements of continuing professional pharmacy education pursuant to subsection B of this section shall satisfactorily pass a written examination approved by the board for that purpose before license renewal.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1939 - Condition of probation; repayment of inspection costs

32-1939.
Condition of probation;  repayment of inspection costs
A. As a condition of probation,  the board may require that a licensee or permittee be subject to additional compliance inspections or audits and pay the reasonable costs of these inspections and audits. These costs shall not exceed one thousand dollars. The board shall limit these additional inspections to no more than two per year.
B. Monies received pursuant to subsection A of this section shall be deposited,  pursuant to sections 35-146 and 35-147,  in the Arizona state board of pharmacy fund.
C. If a licensee or permittee fails to comply with a board order regarding the costs of additional inspections and audits,  the board may enforce its order in the superior court in Maricopa County. The board may also impose additional sanctions against the licensee or permittee.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1940 - Investigations; hearings; conferences; records; confidentiality

32-1940.
Investigations;  hearings;  conferences;  records;  confidentiality
A. Information received and records kept by the board in connection with investigations conducted pursuant to this chapter are confidential and are not open to the public or subject to civil discovery.
B. Notwithstanding any other law or code of ethics regarding practitioner confidences,  the physician-patient privilege between a medical practitioner and a patient,  both as it relates to the competency of the witness and to the exclusion of confidential communications,  does not pertain to any board investigations or other proceedings conducted pursuant to this chapter to the extent necessary to determine whether a violation of this chapter has occurred. Communications or records disclosed pursuant to this subsection are confidential and may be used only in a judicial or administrative proceeding or investigation resulting from a report,  investigation or hearing required or authorized under this chapter.
C. The board,  its employees and agents and any other person receiving this information shall keep the identity of the patient confidential at all times.
D. The board shall report evidence of a crime uncovered during an investigation to the appropriate criminal justice agency.
E. This section does not prevent the board from disclosing investigative materials concerning a licensee's alleged violation of this chapter to the licensee,  the licensee's attorney,  another state or federal regulatory agency or a law enforcement agency.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1941 - Third-party logistics providers; permit required; designated representative; fingerprinting requirements

32-1941.
Third-party logistics providers;  permit required;  designated representative;  fingerprinting requirements
A. A third-party logistics provider that engages in logistics services into,  within or from this state shall hold a third-party logistics provider permit in this state.
B. A third-party logistics provider shall comply with storage practices,  including all of the following:
1. Maintain access to warehouse space of a suitable size to facilitate safe operations,  including a suitable area to quarantine a suspect product.
2. Maintain adequate security.
3. Have written policies and procedures to:
(a) Address the receipt,  security,  storage,  inventory,  shipment and distribution of a product.
(b) Identify,  record and report confirmed significant losses or thefts in the United States.
(c) Correct errors and inaccuracies in inventories.
(d) Provide support for manufacturer recalls.
(e) Prepare for,  protect against and address any reasonably foreseeable crisis that affects a facility's security or operation,  such as an employee strike,  a fire or a flood.
(f) Ensure that any expired product is segregated from other products and returned to the manufacturer,  repackager or agent of the manufacturer or repackager or is destroyed.
(g) Maintain records reflecting the receipt and distribution of products and supplies and records of inventories.
(h) Quarantine or destroy a suspect product if directed to do so by the respective manufacturer,  wholesale distributor or dispenser or an authorized governmental agency.
C. A third-party logistics provider shall make its facility available to the board for inspection during regular business hours to ensure compliance with this section.
D. A third-party logistics provider shall have a designated representative at each facility who has not been convicted of any felony violation under any federal,  state or local law relating to wholesale or retail prescription or over-the-counter dangerous drugs or dangerous devices distribution or the distribution of controlled substances.
E. A third-party logistics provider shall provide the board on the board's request with a list of all manufacturers,  wholesale distributors,  dispensers and durable medical equipment suppliers for whom the third-party logistics provider provides services at a facility.
F. A third-party logistics provider's designated representative shall have a valid fingerprint clearance card issued pursuant to title 41,  chapter 12,  article 3.1,  which shall be submitted with the completed application. If the third-party logistics provider changes its designated representative,  the new designated representative shall have a valid fingerprint clearance card issued pursuant to title 41,  chapter 12,  article 3.1 and submitted to the board before the change in representation is made.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1961 - Limit on dispensing, compounding and sale of drugs

32-1961.
Limit on dispensing,  compounding and sale of drugs
A. Except as otherwise provided in this chapter,  it is unlawful for any person to compound,  sell or dispense any drugs or to dispense or compound the prescription orders of a medical practitioner,  unless that person is a pharmacist or a pharmacy intern acting under the direct supervision of a pharmacist. This subsection does not prevent a pharmacy technician or support personnel from assisting in the dispensing of drugs if this is done pursuant to rules adopted by the board and under the direct supervision of a licensed pharmacist or under remote supervision by a pharmacist.
B. Except as otherwise provided in this chapter,  it is unlawful for any person,  without placing a pharmacist in active personal charge at each place of business,  to:
1. Open,  advertise or conduct a pharmacy.
2. Stock,  expose or offer drugs for sale at retail,  except as otherwise specifically provided.
3. Use or exhibit the title " drug" ,  " drugs" ,  " drugstore" ,  " pharmacy" ,  " apothecary"  or " prescription"  or any combination of these words or titles or any title,  symbol or description of like import or any other term designed to take its place.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1962 - New drug; compliance with federal act; exception

32-1962.
New drug;  compliance with federal act;  exception
A. No person shall manufacture,  sell,  offer or hold for sale or give away any new drug or device unless it fully complies with the provisions of the federal act.
B. This section shall not apply to the nutritional supplement amygdalin,  a cyano-genetic glycoside,  also known as laetrile and vitamin B-17,  which is processed from the seeds of certain fruits including apricots,  peaches and plums.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1963 - Liability of manager, proprietor or pharmacist in charge of a pharmacy; variances in quality of drugs or devices prohibited

32-1963.
Liability of manager,  proprietor or pharmacist in charge of a pharmacy;  variances in quality of drugs or devices prohibited
A. The proprietor,  manager,  and pharmacist in charge of a pharmacy shall be responsible for the quality of drugs and devices sold or dispensed in the pharmacy,  except those sold in original packages of the manufacturer.
B. No pharmacist or other person shall manufacture,  compound,  dispense,  or offer for sale or cause to be manufactured,  compounded,  dispensed,  or offered for sale any drug or device under or by a name recognized in the official compendium or the federal act which differs from the standard of strength,  purity and quality specified therein as official at the time of manufacture,  compounding,  dispensing,  or offering for sale,  nor shall a pharmacist or other person manufacture,  compound,  dispense,  or offer for sale,  or cause to be manufactured,  compounded,  dispensed,  or offered for sale,  any drug or device,  the strength,  purity or quality of which falls below the required strength,  purity or quality under which it is sold.
C. Within four working days of receiving a request,  the proprietor,  manager or pharmacist in charge shall provide the following documents relating to the acquisition or disposal of prescription-only and controlled substance medication if this information is requested by an authorized board agent in the course of his official duties:
1. Invoices.
2. Stock transfer documents.
3. Merchandise return memos.
4. Other related documentation.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1964 - Record of prescription orders; inspections; confidentiality

32-1964.
Record of prescription orders;  inspections;  confidentiality
A. Every proprietor,  manager or pharmacist in charge of a pharmacy shall keep in the pharmacy a book or file in which that person places the original of every prescription order of drugs,  devices or replacement soft contact lenses that are compounded or dispensed at the pharmacy. This information shall be serially numbered,  dated and filed in the order in which the drugs,  devices or replacement soft contact lenses were compounded or dispensed. A prescription order shall be kept for at least seven years. The proprietor,  manager or pharmacist shall produce this book or file in court or before any grand jury on lawful order. The book or file of original prescription orders is open for inspection at all times by the prescribing medical practitioner,  the board and its agents and officers of the law in performance of their duties.
B. The board,  by rule,  shall permit pharmacies to maintain the book or file of all original prescription orders by means of electronic media or image of the original prescription order maintained in a retrievable format in a form that contains information the board requires to provide an adequate record of drugs,  devices or replacement soft contact lenses compounded or dispensed.
C. The board,  by rule,  shall require a similar book or file for a hospital pharmacy in a form that contains information the board requires to provide an adequate record of drugs compounded or dispensed. A prescription order or medication order must be kept for at least seven years. The administrator,  manager or pharmacist must produce this book or file in court or before any grand jury on lawful order. The book or file of original prescription orders or medication orders is open for inspection at all times by the prescribing medical practitioner,  the board and its agents and officers of the law in performance of their duties.
D. A pharmacist,  pharmacy permittee or pharmacist in charge shall comply with applicable state and federal privacy statutes and regulations when releasing patient prescription information.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1965 - Prohibited acts

32-1965.
Prohibited acts
The following acts or the causing of any thereof,  in addition to any others so specified in this chapter,  are prohibited:
1. The manufacture,  sale,  holding or offering for sale of any drug,  device,  poison,  or hazardous substance that is adulterated or misbranded.
2. The adulteration or misbranding of any drug,  device,  poison,  or hazardous substance.
3. The alteration,  mutilation,  destruction,  obliteration,  or removal of the whole or any part of the labeling of,  or the doing of any other act with respect to,  a drug,  device,  poison,  or hazardous substance,  if such act is done while such article is held for sale and results in such article being adulterated or misbranded.
4. The manufacture,  sale,  holding or offering for sale of a counterfeit drug or forging,  counterfeiting,  simulating,  or falsely representing or without proper authority using any mark,  stamp,  tag,  label,  or other identification device authorized or required by rules adopted under the provisions of this chapter,  or of the federal act.
5. The using,  on the labeling of any drug or device,  or in any advertisement,  relating to such drug or device,  of any representation or suggestion that such drug or device complies with the provisions of this chapter.
6. In the case of a prescription-only drug or a controlled substance that requires a prescription order by state or federal law,  the failure of the manufacturer,  packer,  or distributor to transmit,  to any medical practitioner who makes a written request for information about such drug,  true and correct copies of all printed matter included in any package in which that drug is distributed or other printed matter approved under the federal act.
7. Engaging in the practice of pharmacy without first having a current license in good standing issued by the board.
8. Making or offering to make a forged,  counterfeit,  altered or photocopied prescription or drug order for the purpose of obtaining prescription-only or controlled substance drugs.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1966 - Acts constituting adulteration of a drug or device

32-1966.
Acts constituting adulteration of a drug or device
A drug or device shall be deemed to be adulterated:
1. If it consists in whole or in part of any filthy,  putrid or decomposed substance.
2. If it has been produced,  prepared,  packed,  or held under unsanitary conditions whereby it may have been contaminated with filth,  or is not securely protected from dust,  dirt,  and,  as far as may be necessary by all reasonable means,  from all foreign or injurious contamination,  or whereby it may have been rendered injurious to health.
3. If the methods used in,  or the facilities or controls used for,  its manufacture,  processing,  packing,  or holding do not conform to or are not operated or administered in conformity with current good manufacturing practice to assure that such drug or device meets the requirements of this chapter as to safety and has the identity and strength,  and meets the quality,  which it is represented to possess.
4. If its container is composed,  in whole or in part,  of any poisonous or deleterious substance which may render the contents injurious to health.
5. If:
(a) It bears or contains a color additive which is unsafe within the meaning of the federal act.
(b) It is a color additive,  the intended use of which in or on drugs is for the purpose of coloring only,  and is unsafe within the meaning of the federal act.
6. If it is a drug the name of which is recognized in an official compendium,  and its strength differs from,  or its quality or purity falls below,  the standard set forth in such compendium. No drug defined in an official compendium shall be deemed to be adulterated under this paragraph because it differs from the standard of strength,  quality,  or purity set forth in such compendium,  if its difference in strength,  quality,  or purity from such standard is plainly stated on its label.
7. If it is not subject to the provisions of paragraph 6 of this section and its strength differs from,  or its purity or quality falls below that which it purports or is represented to possess.
8. If it is a drug or device to which any substance has been mixed or packed therewith so as to reduce its quality or strength,  or to be substituted for it in whole or in part.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1969 - Filling foreign prescription orders; records; exception

32-1969.
Filling foreign prescription orders;  records;  exception
A. This chapter does not prohibit a pharmacist or an intern under a pharmacist's supervision from filling a new written prescription order for a drug or device issued by a medical practitioner licensed by the appropriate licensing board of a foreign country.
B. The proprietor,  manager or pharmacist in charge of a pharmacy shall keep a separate record of prescriptions filled pursuant to this section.
C. A pharmacist or intern shall not fill a prescription order issued by a medical practitioner licensed by the appropriate licensing board of a foreign country for a controlled substance as defined pursuant to title 36,  chapter 27,  article 2 or the rules adopted pursuant to title 36,  chapter 27,  article 2.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1971 - Compounding pharmacies; certain medications; requirements; definitions

32-1971.
Compounding pharmacies;  certain medications;  requirements;  definitions
A. Chronically ill patients and terminally ill patients have the right to determine,  with the assistance and guidance of their health care providers,  individual courses of treatment through the use of medications and treatments obtained from a compounding pharmacy.
B. Compounding pharmacies that are licensed in this state shall have access to active pharmaceutical ingredients for use in compounding that meet United States pharmacopeia monographs,  if the active pharmaceutical ingredient is prepared for use by a United States food and drug administration-registered active pharmaceutical ingredient manufacturer or packager,  is shipped into this state in compliance with state law and arrives with a certificate of analysis detailing quality specifications,  including any medications,  dietary supplements and amino acids that are already in use by compounding pharmacies in this state,  in order to provide chronically ill patients and terminally ill patients with the prescribed individual course of treatment.
C. Subsection B of this section does not apply if the active pharmaceutical ingredient is deemed unsafe for compounding by the federal food and drug administration or is placed on the interim 503A category II bulk drug substance list. Compounding pharmacies may use substances placed on the interim 503A category III bulk drug substance list only if the substance meets the requirements of this section.
D. This section does not allow any treatment or use of medication that is intended to cause the death of the patient.
E. For the purposes of this section:
1. " Chronically ill patient"  means a patient whose physician has diagnosed the patient as having a long-term disease or condition that if left untreated may cause major irreversible morbidity and who might benefit from individualized or specialized medication that is not commercially available.
2. " Compounding pharmacy"  means a pharmacy that is classified as a 503A pharmacy by the United States food and drug administration.
3. " Monographs"  means quality standards for prescription medicines and dietary supplements that articulate the quality expectations for a medicine or dietary supplement,  including its identity,  strength,  purity and performance.
4. " Terminally ill patient"  means a patient whose physician has diagnosed the patient with a disease that,  taking into account the patient's medical circumstances,  will cause the patient's death in a reasonably foreseeable time.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1973 - Pharmacies; quality assurance

32-1973.
Pharmacies;  quality assurance
A. As prescribed by the board by rule,  each pharmacy shall implement or participate in a continuous quality assurance program to review pharmacy procedures in order to identify methods for addressing pharmacy medication errors. The rules shall prescribe requirements to document compliance and any other provisions necessary for the administration of the program.
B. Records that are generated as a component of a pharmacy's ongoing quality assurance program and that are maintained for that program are peer review documents and are not subject to subpoena or discovery in an arbitration or civil proceeding. This subsection does not prohibit a patient from accessing the patient's prescription records or affect the discoverability of any records that are not generated only as a component of a pharmacy's ongoing quality assurance program and maintained only for that program.
C. A pharmacy meets the requirements of this section if it holds a current general,  special or rural general hospital license from the department of health services and is any of the following:
1. Certified by the centers for medicare and medicaid services to participate in the medicare or medicaid programs.
2. Accredited by the joint commission on the accreditation of health care organizations.
3. Accredited by the American osteopathic association.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1975 - Legend drug products; listing; code identification; exemption; definitions

32-1975.
Legend drug products;  listing;  code identification;  exemption;  definitions
A. A legend drug product in finished solid dosage form shall not be manufactured or commercially distributed within this state unless it is clearly or prominently marked or imprinted with a code imprint identifying the drug product and the manufacturer or distributor of the drug.
B. All manufacturers or distributors of legend drugs in solid dosage form shall make available on request to the board a listing of all such legend drugs identifying by code imprint the manufacturer or distributor and the specific type of drug. The listing shall at all times be kept current by all manufacturers and distributors subject to this section.
C. The board may grant exemptions from the requirements of this section on application of any drug manufacturer or distributor showing size,  physical characteristics or other unique characteristics that render the application of a code imprint to a legend drug subject to this section impractical or impossible. Any exemption granted by the board shall be included by the manufacturer or distributor in the listing required by subsection B of this section,  describing the physical characteristics and type of drug to which the exemption relates.
D. This section does not apply to drug products compounded by a pharmacist licensed under section 32-1924 in a pharmacy operating under a permit issued by the board.
E. For the purposes of this section:
1. " Code imprint"  means a series of letters or numbers assigned by the manufacturer or distributor to a specific drug or marks or monograms unique to the manufacturer or distributor of the drug,  or both.
2. " Distributor"  means a person who distributes for resale a drug in solid dosage form under that person's own label even if that person is not the actual manufacturer of the drug.
3. " Legend drug"  means any drug defined by section 503(b) of the federal food,  drug and cosmetic act and under which definition its label is required to bear the statement " Rx only" .
4. " Solid dosage form"  means capsules or tablets intended for oral use.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1976 - Dispensing replacement soft contact lenses; prescription

32-1976.
Dispensing replacement soft contact lenses;  prescription
A. A prescription order for replacement soft contact lenses may be dispensed under the following conditions:
1. The prescription order shall be in the form required by this chapter and shall include the name of the prescribing physician or optometrist.
2. The prescription order contains the date of issuance.
3. The prescription order for contact lenses includes the lens brand name,  type,  tint and all other specifications necessary to accurately dispense the prescription.
B. The prescription shall be dispensed with the exact lenses prescribed and no substitutions shall be made. The expiration date of the prescription shall be the earlier of the expiration date provided by the prescribing physician or optometrist or one year after the date of issuance. A refill of a prescription that is within sixty days of its expiration date shall be filled with no more than the sufficient quantity of replacement soft contact lenses needed through the expiration date.
C. The prescription shall be dispensed with a written notice containing the following wording or its substantial equivalent:
Warning: If you are having any unexplained eye discomfort,  watering,  vision change or redness,  remove your lenses immediately and consult your eye care practitioner before wearing your lenses again.
D. Any advertisement by a pharmacy or pharmacist for replacement soft contact lenses shall include all charges associated with the purchase of replacement soft contact lenses from the pharmacy or pharmacist.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1978 - Sale of dextromethorphan; age requirement; exception; violation; civil penalty; definitions

32-1978.
Sale of dextromethorphan;  age requirement;  exception;  violation;  civil penalty;  definitions
A. It is prohibited for:
1. Any commercial entity to knowingly or wilfully sell or trade a finished drug product containing any quantity of dextromethorphan to a person who is under eighteen years of age.
2. Any person who is under eighteen years of age to purchase a finished drug product containing any quantity of dextromethorphan.
3. Any person to possess,  receive or distribute unfinished dextromethorphan,  unless the person is registered pursuant to the federal food,  drug,  and cosmetic act or is appropriately licensed with the board.
B. A person making a retail sale of a finished drug product containing any quantity of dextromethorphan must require and obtain proof of age from the purchaser before completing the sale,  unless the person making the sale reasonably presumes the purchaser to be at least twenty-five years of age based on the purchaser's outward appearance.
C. Subsection A of this section does not apply to common carriers that possess,  receive or distribute unfinished dextromethorphan for purposes of distributing such unfinished dextromethorphan between persons that are registered under section 510 of the federal food,  drug,  and cosmetic act or that are appropriately licensed with the board.
D. This section does not impose any compliance requirement on a retail entity other than manually obtaining and verifying proof of age as a condition of sale,  including placement of products in a specific place within a store,  other restrictions on a consumer's direct access to finished drug products or the maintenance of transaction records.
E. A person who sells or trades a finished drug product containing any quantity of dextromethorphan to a person who is under eighteen years of age shall receive a warning for a first offense and shall pay a civil penalty of fifty dollars for a second offense,  unless the person provides documentation that there is an employee training program in place.
F. This section does not apply to a medication containing dextromethorphan that is sold pursuant to a valid prescription.
G. For the purposes of this section:
1. " Common carrier"  means any person that holds itself out to the general public as a provider for hire of the transportation of merchandise,  whether or not the person actually operates the vehicle by which the transportation is provided within,  to or from the United States.
2. " Finished drug product"  means a drug that is legally marketed under the federal food,  drug,  and cosmetic act and that is in finished dosage form.
3. " Unfinished dextromethorphan"  means dextromethorphan in any form,  compound,  mixture or preparation that is not a finished drug product.
2023 Arizona Revised Statutes › Title 32 - Professions and Occupations › § 32-1979 - Pharmacists; dispensing opioid antagonists; board protocols; immunity

32-1979.
Pharmacists;  dispensing opioid antagonists;  board protocols;  immunity
A. A pharmacist may dispense,  pursuant to a standing order issued pursuant to section 36-2266 and according to protocols adopted by the board,  naloxone hydrochloride or any other opioid antagonist that is approved by the United States food and drug administration for use according to the protocols specified by board rule to a person who is at risk of experiencing an opioid-related overdose or to a family member or community member who is in a position to assist that person.
B. A pharmacist who dispenses naloxone hydrochloride or any other opioid antagonist pursuant to subsection A of this section shall:
1. Document the dispensing consistent with board rules.
2. Instruct the individual to whom the opioid antagonist is dispensed to summon emergency services as soon as practicable after administering the opioid antagonist.
C. This section does not affect the authority of a pharmacist to fill or refill a prescription for naloxone hydrochloride or any other opioid antagonist that is approved by the United States food and drug administration.
D. A pharmacist who dispenses an opioid antagonist pursuant to this section is immune from professional liability and criminal prosecution for any decision made,  act or omission or injury that results from that act if the pharmacist acts with reasonable care and in good faith,  except in cases of wanton or wilful neglect.